Monte Rosa Therapeutics (GLUE) announced the company will present preclinical data at the 36th EORTC-NCI-AACR Symposium, ENA 2024, taking place ...

Exchange Traded Concepts LLC decreased its stake in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) by 16.5% in the ...

(ANSA) - ROME, SEP 9 - One person is dead and four are injured after an avalanche hit a group of eight climbers on the ...

How come we can’t travel to Tilbury and board the Museum Ship Empire Windrush? Where is it? The short answer: it sank. The ...

Roche seems determined to develop a commanding position in the emerging molecular glue category, signing up to a $2 billion partnership with Monte Rosa Therapeutics that includes a $50 million ...

Three of the four of us are CrossFitters, and we wanted to get to a gym at least once while we were in Italy. The coach at ...

HMT Empire Windrush became synonymous with the voyage it completed in 1948, transporting hundreds of West Indians and people ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

波士顿 - 专注于开发分子胶降解剂(MGD)药物的生物技术公司Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE)在西班牙巴塞罗那举行的第36届EORTC-NCI-AACR研讨会上展示了临床前数据。这些数据突显了其cyclin E1靶向MGD在治疗CCNE1扩增的实体瘤方面的潜力。Cyclin E1 (CCNE1)是一种在细胞周期进程中发挥关键作用的癌基因,在多 ...

Located in the south-western part of Switzerland, close to the French and Italian borders and home to the picturesque Rhone ...